Stocks/TRNS

TRNS

Transcat, Inc.
Industrials·Industrial - Distribution
$84.52
$789M market cap
Claude Rating
4/10UNDERWEIGHT
Revenue
$316.6M
Free Cash Flow
$26.4M
Rev Growth
-4.9%
FCF Margin
8.3%
P/FCF
29.9x
EV/FCF
34.8x
Fwd EV/EBITDA
18.7x
Fair Value
$58.00
Upside
-31.4%

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service

2-Year Price History

$73.02-42.2%
$60$80$100$120$140volJun 24Oct 24Jan 25May 25Sep 25Jan 26May 26

Quarterly Financials & Projections

Quarterly Waterfall ($ M)
PeriodRevEBITDAOpInNIOCFFCFCapExCashDebtSharesROICIntCovEV/EBITDA
Est2028-Q396.014.9--4.8--10.6-3.265.7----------
Est2028-Q293.514.2--4.2--8.9-3.355.1----------
Est2028-Q187.512.3--2.6--4.8-3.346.3----------
Est2027-Q492.014.3--4.1--9.7-3.241.4----------
Est2027-Q390.013.3--3.6--9.0-3.231.8----------
Est2027-Q288.012.8--3.1--7.0-3.522.8----------
Est2027-Q182.011.1--2.1--4.1-3.315.7----------
Est2026-Q486.012.0--2.6--8.2-3.011.6----------
Act2026-Q373.49.76.03.712.29.5-2.73.5134.09.05.6%8.4x20.5x
Act2025-Q383.97.20.1-1.112.29.5-2.73.5134.09.30.1%4.8x19.2x
Act2025-Q282.39.83.51.312.98.4-4.45.1147.89.43.1%7.7x22.1x
Act2025-Q177.112.46.94.53.6-1.0-4.61.965.79.37.4%26.2x18.2x
Act2024-Q477.112.46.94.510.67.9-2.71.557.79.37.7%26.2x27.0x
Act2024-Q367.88.23.73.312.69.7-2.94.666.09.34.9%107.8x29.0x
Act2024-Q267.88.23.73.36.82.9-4.023.817.79.36.2%107.8x26.8x
Act2024-Q166.79.45.14.48.95.3-3.722.722.29.28.0%180.6x24.3x
Act2023-Q470.913.49.26.95.71.6-4.235.221.58.614.4%267.1x24.6x
Act2023-Q365.28.14.33.410.97.3-3.735.222.18.87.7%100.2x24.9x
Act2023-Q262.88.31.60.58.45.8-2.71.367.88.03.6%9.4x24.5x
Act2023-Q160.67.44.63.07.54.8-2.82.262.57.813.8%9.1x26.7x
Act2022-Q462.18.65.93.73.00.7-2.31.564.47.718.4%8.3x22.9x
Act2022-Q357.45.73.21.68.76.4-2.41.662.27.711.0%7.8x--
Act2022-Q256.46.43.62.43.20.8-2.40.963.67.712.2%11.9x--
Act2022-Q154.76.33.63.12.0-0.4-2.40.462.67.614.1%40.0x--
Historical Valuation

Multiples vs the company's own history — cheap or rich relative to itself? Historical fiscal years, then TTM, then forward projections (E). Forward rows hold today's price against projected earnings, so the multiple compresses if the company grows into it.

YearPriceRev GrEBITDA %EBITDAEV/EBITDAEV/FCFP/EP/S
202270.8711.7%2724.4×87.0×55.5×2.6×
2023109.33+12.5%14.3%3721.7×41.7×60.1×3.2×
2024105.74+7.7%13.6%3829.6×43.8×69.4×3.8×
TTM84.52+13.3%12.3%390.0×0.0×0.0×0.0×
2027E84.52+11.2%0.1%10.0×0.0×0.0×0.0×

EBITDA in reporting-currency $M. Historical multiples use year-end market cap (split-adjusted price history); TTM & forward years use today's.

AI Analysis

LLM Evaluations

Claude4/10UNDERWEIGHTFV: $58.00

Transcat operates in an attractive niche — recurring calibration services in regulated industries — with a proven 67-quarter organic growth streak and a fragmented market ripe for consolidation. However, the stock is significantly overvalued at 88x trailing P/E and 29x FCF for a business currently generating sub-3% net margins with declining ROIC and a CEO transition underway. The acquisition-led growth strategy has loaded the balance sheet with $348M of goodwill/intangibles (74% of assets), leverage has risen from near-zero to 2x, and the core Service segment is running at an operating loss. While the long-term secular thesis around regulated calibration demand is intact, the current valuation demands flawless execution on integration, margin recovery, and organic growth acceleration — a high bar during a leadership change. The market is pricing in a best-case compounding scenario that ignores near-term execution risks and the quality deterioration in earnings.

Catalyst New CEO Jaime Irick could either catalyze a re-rating if he articulates a credible margin recovery plan and delivers strong organic growth, or trigger a derating if integration stumbles or M&A pauses. Successful margin recovery to 6%+ net margins over the next 4 quarters would be the key positive catalyst. Conversely, continued margin compression or an acquisition impairment would expose the short.
Risk The single biggest risk is that the market re-rates the stock higher on continued strong revenue growth and improving organic service trends, ignoring near-term margin headwinds. The calibration services business has genuine secular tailwinds (onshoring, regulation, defense) that could sustain premium multiples longer than expected.
Trend
IMPROVING
Mgmt
6/10
Quarter
6/10
Exp. Move
-3.0%

Latest Earnings Call

Transcript Summary

Transcat reported robust Q3 fiscal 2026 results, with consolidated revenue up 26% to $83.9 million. A key highlight was the return of organic service growth to 7%, continuing a 67-quarter growth streak. Service revenue reached $53.7 million, while Distribution revenue climbed 20% to $30.2 million, bolstered by high-margin rental growth in power generation and data center markets. Adjusted EBITDA rose 27.2% to $10.1 million. The company reported a small GAAP net loss due to acquisition amortization and CEO succession costs. Management reaffirmed high single-digit organic growth for Q4. The integration of Martin and Essco acquisitions is progressing well, expanding the firm’s geographic and technical reach. The CEO search is nearing its end, with an announcement expected by fiscal year-end. Analysts questioned the impact of large-scale domestic pharmaceutical onshoring and defense spending; management noted these trends provide significant long-term tailwinds for recurring calibration revenue. Transcat remains well-capitalized with a 2x leverage ratio and $50.1 million in available liquidity for future M&A.

Valuation & Metrics

Market Stats

Price$84.52
Market Cap$789M
Enterprise Value$920M
P/S Ratio2.5x
P/FCF29.9x
EV/FCF34.8x
FCF Margin (TTM)8.3%
FCF Yield3.3%
Dividend Yield (TTM)--
Annual Dilution-2.7%
CurrencyUSD

TTM Financial Snapshot

Revenue$316.6M
Net Income$8.3M
Free Cash Flow$26.4M

Revenue Growth (YoY)-4.9%
EBITDA Margin12.3%
Net Margin2.6%
FCF Margin8.3%
CapEx % of Revenue4.5%
SBC % of Revenue2.8%
ROIC4.0%
WC Change % Rev-0.4%
Interest Coverage8.9x

DCF Fair Value Estimate

$36.44
-56.9% upside
Fair Enterprise Value$458M
− Net Debt$131M
= Fair Equity$328M
Revenue Growth6.6% → 6.0%
FCF Margin8.3% → 12.0%
Discount Rate14.0%
Terminal EV/FCF16.0x

Forward Outlook & Risk

Short Interest

Short % of Float5.7%
Short Shares0.5M
Days to Cover4.2
Change (vs Prior)-11.5%
Short % Float History
5.70%-0.40pp
4.0%4.5%5.0%5.5%6.0%6.5%04-3007-1509-1511-1401-1504-30

Options

Call IV (ATM)51%
Put IV (ATM)52%
ATM Spread0.69%
Call $OI (near money)$1.1M
Put $OI (near money)$6K
ATM ExpiryJuly 17, 2026 (56D)
ATM Strike$75.0
Major Expirations4
Near-money chain · July 17, 2026
StrikeCall Bid/AskCall OIPut Bid/AskPut OI
$55.00$18.90/$19.700$0.90/$1.200
$60.00$14.70/$15.400$1.55/$1.900
$65.00$10.80/$11.500$2.65/$3.100
$70.00$7.50/$8.100$4.20/$4.900
$75.00$4.90/$5.400$6.50/$7.000
$80.00$3.00/$3.500$9.60/$10.200
$85.00$1.85/$2.250$13.30/$14.000
$90.00$1.05/$1.400$17.50/$18.300
Snapshot: 2026-05-22

Forward Projections & Estimates

NTM Revenue Growth+9.3%
Forward FCF Margin8.2%
Forward EBITDA Margin14.2%
Forward P/FCF27.9x
Forward EV/FCF32.5x
Forward Int. Coverage10.3x
Model Risk Score6/10
Bankruptcy Odds2%
Est. Borrow Rate6.5%
Terminal EV/FCF16.0x
LT Growth6.0%
LT FCF Margin12.0%

Employees

Headcount1,104
Revenue / Employee$286,786
Gross Profit / Employee$93,250
2022: 918 → 2023: 1,030 → 2024: 1,104 → 2025: 1,245 (11% CAGR)

Institutional Ownership

Headline & net flow

NET BUYING

In Q1 2026 so far (quarter still filing), institutions are net buyers — bought 25.0% of float, sold 12.8%. 7 filers moved >1% of shares (5 buying, 2 selling).

Net flow · Q1 2026still filing
+12.2% of float (net)
Bought 25.0% · Sold 12.8%
100 filers reported (last quarter: 151)

Ownership composition

Active
81.2%(-0.3% YoY)
145 filers
hedge / family / endowment
Retail funds
Fidelity, Schwab, 401(k)
Passive
22.7%(+0.6% YoY)
11 filers
Vanguard, iShares, SPDR
Market makers
0.0%(-0.5% YoY)
3 filers
Citadel, Susquehanna
Insiders
1.8%
Form 4 — latest per insider
0%25%50%75%100%2022-062023-032023-122024-092025-062026-03
ActiveRetail fundsPassiveMarket makersRetail direct

Top holders

Fund$ valueCost basisΔ QoQΔ YoYα lifeFund AUM
Neuberger Berman Group LLC$60.7M$101.19−$1.8M−$7.1M-0.3%$131.37B
BlackRock, Inc.Passive$49.6M$119.05−$415K+$713K-0.2%$5.69T
Hood River Capital Management LLC$45.1M$85.06+$5.0M+$20.1M-1.0%$9.97B
ROYCE & ASSOCIATES LP$45.1M$80.11+$16.4M+$10.0M-0.9%$10.09B
Ophir Asset Management Pty Ltd$40.1M$73.45+$40.1M+$40.1M+0.6%$859M
Conestoga Capital Advisors, LLC$37.6M$78.59−$31.7M−$32.7M-2.6%$4.90B
VANGUARD CAPITAL MANAGEMENT LLCPassive$29.9M$73.45+$29.9M+$29.9M$4.04T
BARROW HANLEY MEWHINNEY & STRAUSS LLC$24.1M$73.45+$24.1M+$24.1M+0.5%$30.45B
RIVERBRIDGE PARTNERS LLC$22.8M$105.09−$2.0M+$6.1M-2.0%$4.09B
WELLINGTON MANAGEMENT GROUP LLP$21.9M$60.57+$3.6M+$21.9M-0.3%$533.98B
DIMENSIONAL FUND ADVISORS LPPassive$19.2M$81.23+$681K+$3.4M-0.4%$480.92B
Paradice Investment Management LLC$18.2M$73.45+$18.2M+$18.2M-4.0%$527M
BAMCO INC /NY/$16.9M$73.97+$2.0M+$5.6M-2.4%$33.05B
GEODE CAPITAL MANAGEMENT, LLCPassive$16.8M$100.17+$455K+$712K+2.3%$1.61T
STATE STREET CORPPassive$16.1M$103.26+$10K−$25K-0.2%$2.89T
Champlain Investment Partners, LLC$15.0M$99.28−$2.8M−$28.9M-2.5%$7.75B
First Eagle Investment Management, LLC$11.2M$59.47+$1.8M+$11.2M+0.7%$58.96B
ArrowMark Colorado Holdings LLC$11.1M$64.57+$1.2M+$11.1M-4.3%$3.74B
ROYAL BANK OF CANADA$9.7M$96.95−$2.1M−$2.3M-0.2%$526.36B
NEEDHAM INVESTMENT MANAGEMENT LLC$9.6M$80.51+$450K+$4.8M-0.1%$1.95B
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.

Trading behavior

Smart-money alpha (lifetime, %/qtr)BULLISH
Holders
-0.84%
avg per quarter
Holders (ex-self)
-0.84%
excl. this stock
Buyers (this Q)
-0.65%
85 buyers · $0.24B in
Sellers (this Q)
-2.96%
51 sellers · $0.01B out
alpha coverage: 94% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
-10.1%
how holders react when this stock falls
On quiet Qs
-19.6%
−10% to +10% baseline
On rallies (+10%+)
-16.1%
how they react when this stock rises
Holders' portfolio flow this Q
-1.9%
outflows — trims may be forced
Sellers' portfolio flow this Q
-23.0%
Sellers shed AUM broadly — partly forced.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
-3.5%
Holder mid (any stock)
-3.1%
Holder rally (any stock)
-5.7%

Top Holders Over Time

5-year share-count history (top 10 holders by peak, incl. exited) + price

01.2M2.4M3.5M4.7M$57$73$89$105$1212021-062022-062023-062024-062025-062026-03
hover the chart for per-quarter detailprice (right axis)
Conestoga Capital Advisors, LLC513KNeuberger Berman Group LLC826KWASATCH ADVISORS INCFRED ALGER MANAGEMENT, LLCROYCE & ASSOCIATES LP614KChamplain Investment Partners, LLC204KT. Rowe Price Investment Management, Inc.Hood River Capital Management LLC615KBroadcrest Asset Management, LLCOphir Asset Management Pty Ltd546K

Analyst Coverage

Analyst Coverage
Price Targets
Last Year (1 analysts)$95.001240.0%
Current Price$84.52
Analyst Ratings
8
2
Buy: 8Hold: 2Consensus: Buy
Consensus Estimates
QuarterRevenueEBITDANet IncEPSEPS Range# Analysts
2024 Q470M12M4M$0.45$0.41 – $0.482
2025 Q177M13M5M$0.52$0.46 – $0.562
2025 Q272M12M4M$0.40$0.39 – $0.403
2025 Q380M14M5M$0.49$0.43 – $0.554
2025 Q481M14M3M$0.32$0.27 – $0.353
2026 Q190M15M5M$0.56$0.51 – $0.603
2026 Q285M14M5M$0.49$0.48 – $0.492
2026 Q389M15M5M$0.53$0.53 – $0.541
2026 Q488M15M4M$0.41$0.40 – $0.411
2027 Q195M16M6M$0.70$0.69 – $0.701

Corporate

Executive Compensation (2023-2025)

Direct Pay$19.3M
Incentive & Other$6.4M
Total Compensation$25.6M
% of Revenue3.0%

Order Flow (FINRA, ~3w lag)

8.2%retail-1.9pp
22.6%dark-12.1pp
week of 2026-04-13
10%20%30%40%24-1125-0225-0525-0825-1126-0226-04retail (non-ATS)dark (ATS)
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.

Revenue Breakdown

Revenue Segments

By Product (2025-Q3)
Service$53.7M+29%
Distribution Service$30.2M+20%
By Geography (2025-Q3)
UNITED STATES$78.8M+29%
CANADA$3.9M-12%

Filing Risk Analysis

Filing Risk Scores

Transcat, Inc.: Aggressive M&A Strategy Masking Margin Collapse and Executive Transition Dilution

Overall Risk
7/10
Fraud
3/10
Dilution
6/10
Insolvency
4/10
Earnings Overstated
6/10
Hidden Liabilities
5/10
Legal
2/10
Audit Warnings
4/10
Hidden Upside
2/10
Contextually Acceptable
4/10

Counter-Thesis

Counter-Thesis & Recent News

📰 Recent News

In February 2026, Transcat reported a Q3 2026 net loss of $1.1 million, a significant reversal from the prior year's profit. This loss was attributed to elevated interest expenses, one-time CEO succession charges, and higher amortization from its two largest-ever acquisitions, Martin and ESCO Calibration. Additionally, the company underwent a major leadership transition as long-time CEO Lee Rudow retired on March 29, 2026, replaced by Jaime Irick, which introduces execution risk during the integration of recent high-stakes acquisitions (Sources: MarketBeat, Transcat Investor Relations).

🐻 Bear Case

The bear case centers on severe margin compression and an unsustainable valuation. Trailing net profit margins plummeted to 2.5% from 6.2% a year earlier. Despite revenue growth, earnings per share (EPS) declined by 6.8% annually over the last two years, indicating that the company is struggling to convert top-line growth into profit. Bears argue the stock is 'priced for perfection' with a P/E ratio exceeding 88x, while DCF models estimate a fair value closer to $31—roughly 60% below current trading levels (Sources: Simply Wall St, IndexBox).

🚩 Red Flags

Significant analyst downgrades have emerged in April 2026, with Zacks Research slashing TRNS to a 'Strong Sell' and Weiss Ratings maintaining a 'Sell (D+)' grade. A recurring red flag is the company’s recent earnings miss, reporting $0.26 EPS against a $0.30 consensus. Furthermore, the company’s return on invested capital (ROIC) has been declining, suggesting that its aggressive acquisition-led strategy may be yielding diminishing returns (Sources: MarketBeat, Zacks Research).

⚔️ Competitive Threats

Transcat faces intensifying competition from low-cost, web-based retailers in its distribution segment, which threatens its traditional market position. In the service segment, the company faces the risk of 'acquisition indigestion'—the high complexity and cost of integrating large-scale competitors like ESCO could allow nimbler regional players to capture market share if service quality or lead times fluctuate during the transition (Sources: Public.com, Transcat Q3 Earnings Call).

💬 Customer Sentiment

While management claims strong retention, analyst reports suggest a weakening in pricing power. There are growing concerns that Transcat has been unable to pass rising labor and operational costs on to its customers, leading to the current margin erosion. This suggests a price-sensitive customer base that may resist further increases, limiting the company's ability to recover profitability through organic price hikes (Source: IndexBox Analysis).

Full Earnings Call Transcript

Full Earnings Call Transcript — Q3 • 2026-02-03

Operator: Good afternoon, ladies and gentlemen. Welcome to the Transcat Third Quarter Fiscal Year 2026 Financial Results Conference Call. As a reminder, today's conference is being recorded. It is now my pleasure to introduce your host for today, Mr. John Howe, Senior Director of Financial Planning and Analysis. Please go ahead, sir.
John Howe: Thank you, operator, and good afternoon, everyone. We appreciate your time and your interest in Transcat. With me here on the call today is our President and CEO, Lee Rudow, and our Chief Financial Officer, Tom Barbato. We will begin the call with some prepared remarks, and then we will open the call for questions. Our earnings release crossed the wire after markets closed this afternoon. Both the earnings release and the slides that we will reference during our prepared remarks can be found on our website, transcat.com in the Investor Relations section. If you would, please refer to Slide 2. As you are aware, we may make forward-looking statements during the formal presentation and Q&A portion of this teleconference. These statements apply to future events which are subject to risks and uncertainties as well as other factors that could cause the actual results to differ materially from where we are today. These factors are outlined in the news release as well as in the documents filed by the company with the SEC. You can find those on our website where we regularly post information about the company as well as on the SEC's website at sec.gov. We undertake no obligation to publicly update or correct any of the forward-looking statements contained in this call whether as a result of new information, future events or otherwise, except as required by law. Please review our forward-looking statements in conjunction with these precautionary factors. Additionally, during today's call, we will discuss certain non-GAAP measures, which we believe will be useful in evaluating our performance. You should not consider the presentation of this additional information in isolation or as a substitute for results prepared in accordance with GAAP. We've provided reconciliations of non-GAAP to compared GAAP measures in the tables accompanying the earnings release. With that, I'll turn the call over to Lee.
Lee Rudow: Okay. Thank you, John. Good morning, everyone. We appreciate you joining us on the call today. Transcat delivered strong performance across our entire business portfolio in the third quarter. Consolidated revenue was up 26% to $83.9 million, driven by double-digit revenue growth in both our distribution and service segments. Our organic service growth returned to more historic levels growing 7%. Consolidated gross profit grew 28% and gross margins expanded 60 basis points. Adjusted EBITDA grew $2.2 million or 27.2% in the quarter, to $10.1 million. Our strong third quarter financial results were driven by 4 key factors: one, strong demand for our core calibration services in the highly regulated end markets we serve, including life science, aerospace and defense and energy; two, our unique value proposition and differentiated brand; three, significant growth and positive mix change in our instrument rental channel; and four, the strong performance by both our recently acquired companies, Martin calibration and Essco calibration. The acquisitions expand Transcat's geographic footprint and technical capabilities. We're working very closely with both companies to accelerate the capture of both sales and cost synergies. I'd like to take a moment and thank our entire Transcat team for their ability to execute well and drive meaningful growth despite what continues to be an uncertain geopolitical and policy environment. They are an impressive group. Turning to our service results in the third quarter. As I mentioned, organic growth grew 7% and contributed to an overall growth in our Service segment of 29%. The quarter marked our 67th straight quarter of year-over-year growth, almost 17 years. As we anticipated and despite a fair amount of continued economic uncertainty, realization of service orders that were delayed in the first 2 quarters of our fiscal year began to trend positive in the third quarter. The trend was most evident in the highly regulated life science space and the aerospace and defense markets. Demand for Transcat services remains high, and we expect the growth momentum established in the third quarter to continue through the fourth quarter, as we close out our fiscal year. Service margins declined in the third quarter, but that is not uncommon in periods when we are onboarding elevated levels of new customers. Depending on the size and the complexity of the new business, as we've seen in the past, we would expect productivity and cost to normalize over time. Overall, the Service segment continues to have a substantial runway ahead for growth, both organically and through acquisition. So at the last 10-plus years, we've demonstrated our ability to identify, acquire, integrate and synergistically grow accretive acquisitions. This will continue to be an important element of our go-forward growth strategy. Turning to distribution in the third quarter. Distribution revenue grew 20% from high demand in both rentals and product sales. Gross margin expanded 330 basis points versus prior year, driven primarily by an increase in the mix of higher-margin rental revenue within the Distribution segment. With that, I'll turn things over to Tom for a more detailed look at our third quarter financial results.
Thomas Barbato: Thanks, Lee. I'll start on Slide 4 of the earnings deck, which provides detail regarding our revenue on a consolidated basis and by segment for the third quarter of fiscal 2026. Third quarter consolidated revenue of $83.9 million was up 26% versus the prior year as both segments grew double digits. Looking at it by segment, Service revenue grew 29% with organic revenue growth of 7% and the balance of the growth the result of the Martin calibration and Essco calibration acquisitions. Turning to distribution. Revenue of $30.2 million grew 20%, driven by strong performance in both traditional product sales and rentals. Turning to Slide 5. Our consolidated gross profit for the second quarter of $25.3 million was up 28% from the prior year. Service gross profit increased 25% from the prior year. We continue to leverage higher levels of technician productivity and our differentiated value proposition. The service gross margins historically lagged as we incur start-up costs related to the onboarding of new customers. Distribution segment gross profit of $9.8 million was up 34% with 330 basis points gross margin expansion, driven by growth in the higher-margin rental channel. Turning to Slide 6. Q3 net loss of $1.1 million decreased versus prior year, driven by higher amortization expense related to both the Martin and Essco calibration acquisitions. The 2 largest in Transcat's history, as well as higher levels of interest expense and onetime charges related to the execution of the CEO succession plan. Our search committee is evaluating both internal and external candidates for our next CEO, and the process is nearing completion. In addition, we reported adjusted diluted earnings per share to normalize for the impact of upfront and ongoing acquisition-related costs as well as costs that are not directly tied to ongoing operations. Q3 adjusted diluted earnings per share was $0.26. Flipping to Slide 7, where we show our adjusted EBITDA and adjusted EBITDA margin. We use adjusted EBITDA, which is non-GAAP to gauge the performance of our business because we believe it is the best measure of our operating performance and ability to generate cash. As we continue to execute on our acquisition strategy, this metric becomes even more important to highlight as it does adjust for onetime deal-related transaction costs as well as increased levels of noncash expenses that will hit our income statement from acquisition purchase accounting. Third quarter consolidated adjusted EBITDA of $10.1 million increased 20% -- 27% from the same quarter in the prior year, with 10 basis points of margin expansion. As always, a reconciliation of adjusted EBITDA to operating income and net income can be found in the supplemental section of this presentation. Moving to Slide 8. Operating cash flow was slightly lower versus prior year as net cash from operations increased but was offset by higher capital expenditures. CapEx is in line with expectations and continues to be centered around Service segment capabilities, rental pool assets, technology and future growth projects. Slide 9 highlights our strong balance sheet. At quarter end, we had total debt of $99.9 million. $50.1 million available for borrowing under the secured revolving credit facility and a leverage ratio of 2x. The growth in adjusted EBITDA and associated margin enabled Transcat to continue a sequential reduction in our leverage ratio. We believe we are well positioned to grow both organically and through acquisition. Lastly, our 10-Q was filed today after the market closed. With that, I'll turn it back to you, Lee.
Lee Rudow: Okay. Thank you, Tom. In the third quarter, we returned to more historic organic service growth levels by achieving 7% growth, and we are off to a good start in the fourth quarter as we continue to experience an increased level of customer activity, strong retention and realization of new business. For these reasons, we reaffirm our fourth quarter organic service revenue growth expectations to be in the high single-digit range. As fiscal 2026 comes to a close, we anticipate our results for the year will once again be a testament to our resilience and our differentiated business model that is anchored by recurring revenue streams, driven by both regulation and the high cost of failure. We maintain a strong and stable balance sheet that supports our demonstrated growth strategy, our ability to acquire and integrate companies that increase our geographic footprint, and colitis or just bolt on to existing infrastructure. This drives both consistent value and synergistic growth opportunities. We have a strong acquisition pipeline that will enable opportunities to expand our addressable markets and increase market share. Over the past couple of years, we've invested in leadership, technology and overall process improvement. We are well positioned for the age of AI as our data sets are much improved and already contributing to incremental business insights that make Transcat a very difficult company to compete with. We believe our investments are and will continue to drive differentiation for Transcat and foster our ability to continue to generate sustainable long-term value for our shareholders. With that, operator, we can open the line for questions.
Operator: [Operator Instructions] We'll go first this afternoon to Greg Palm of Craig-Hallum. Greg.
Greg Palm: Congrats on getting back to that high single-digit revenue growth in the quarter for segment, maybe starting there, it would be nice if you could just maybe sort of bucket out the various drivers that enabled you to return to that growth sounded like it was just sort of a ramp-up of everything you've been talking about, but I'm not sure if there was anything specific you wanted to highlight?
Thomas Barbato: No, Greg, I mean, I think as we talked about in the past, we some of these decisions have been delayed. We had kind of coming into the quarter. We had some income paper in some cases, and we knew that those would ramp throughout the quarter. There were other deals we anticipated would come to fortune and they did. So we feel good about the performance. I think we did what we said we were going to do. And we expect, as Lee mentioned in his prepared remarks, that will continue into Q4. PAUSE.
Greg Palm: Okay. And the start-up costs, which I know you've incurred in the past, so that's nothing new. But are you able to quantify how big of a headwind that was? I don't know if it was related to CBL specifically or something different? And just from a time line or what we should expect in the near term? When does all that stuff start to normalize? Or I guess when does the new business wins fall off and those just become normalized going forward?
Thomas Barbato: Yes. I mean we're not talking huge dollars. I would just say you could do some simple math and look at the difference between where we were and if we were flat or slightly accretive from a margin standpoint, right? It's not huge numbers, but it's just the reality of onboarding new customers and for us, the most important thing is to make sure that as we start these new partnerships that we get off to a good start, we're doing things right. We're treating the customers writing. We're doing everything we can to start a good relationship. And there's -- in often cases, there's a reason why these customers are moving to Transcat, right? They want things done right. They want things spend with a higher level of quality and that's our focus and making sure we get off to the right start.
Lee Rudow: And Greg, I would add to that. The way we view some of these large customers and really all of our customers, some of them have a real high lifetime value. And so making sure they get off to the right start is a priority for us. And sometimes, there's some costs associated with that, that just go away over a couple of quarters. And then you mentioned CBLs, we saw that in the past, right? So this is not dissimilar.
Greg Palm: Okay. And then lastly, distribution was another, obviously, really strong quarter of revenue growth. Can you maybe talk to us a little bit about what you're doing there in the AI, the data center/power gen markets. And then just broadly speaking, is there a longer-term opportunity on the calibration services segment, again, longer term?
Thomas Barbato: Yes. I mean I think what are we doing? I mean we're -- I think we're executing very well on the distribution side, both on the traditional equipment sales side as well as rentals. And as we've talked about also, we made a conscious effort 18 or 24 months ago to really invest fairly heavily in rentals for products used in, I'll just say the power generation, power conditioning, power management space, which aligns very well, not only with data centers, but EV charging needs and that sort of thing and it's really serving us well. I think from a product sales standpoint, we're positioned well to support those cement markets. And there absolutely are recurring calibration opportunities that are and will continue to come along with those end markets. So I think it's an area we're excited for. I mean it's -- I mean you read about it every day in the news, right? So I think the fact that we've got alignment and we're kind of going aggressively after the business is an opportunity for us.
Operator: We go next now to Max Michaelis at Lake Street Capital Markets.
Maxwell Michaelis: I want to go back to the service growth. Congratulations on returning to high single-digit growth at 7%. When you look at Q4 2026. Do you expect to see an acceleration things to get better from the 7%? Or should we expect to kind of be in the same sort of range. And then when we think about beyond next quarter, how has been -- how are the conversations been with customers around new business, I guess, going out into fiscal year '27?
Thomas Barbato: Yes. Max, it's Tom. So I would just say that we're committed to the high single-digit guidance that we've provided for Q4, I think when you look at Q4 and you look at last year was a really strong Q4 for us as well, right? So we're kind of building off a big number, right? And we're comfortable in that high single-digit range. When we look beyond Q4, we're not giving any specific guidance at this point, but we'll just say that our pipeline -- our new business pipeline continues to be strong, and we like we're positioned and we think we've got the pipeline to support continued growth going forward.
Maxwell Michaelis: Okay. That makes sense. And then I guess, maybe around M&A, what are you seeing in the space? And maybe could we expect to see sort of I guess, remind us where sort of the geographic locations you guys are looking to get into and kind of maybe where you're at and sort of the progress there.
Thomas Barbato: Yes. So the gaps that we always talk about, right, at this point, there's 4. This time last year, 18 months ago, they would have been 6, right? But -- and we filled some of those holes. But Northern California is an area we want to be, Dallas, We'd love to be in the Atlanta area and then the Mid-Atlantic that kind of Baltimore areas are voiding for us. We're able to service it from other locations, but there's enough business there that we'd like to physically be there. And then there's -- when we talk about other -- there's other opportunities to follow our customers, right? And we're always looking to get that. And whether it's potentially -- we've recently expanded our presence in Ireland, right, and that's going very well for us. There could be other potential opportunities in Europe, there could be other potential opportunities as an example in North America or Central America to just make sure that we're properly servicing and we have the locations to service our existing customer base properly so.
Maxwell Michaelis: Okay. And then just the last one for me is around gross margin. I know you mentioned in the last question about sort of cost isn't something you've dealt with in the past. But if we look at next quarter, and I know you're taking on a lot of new business, is some of the costs you incurred this quarter in sort of preparation for the new business in the next quarter? Are we going to see similar gross margins probably from the Service segment next quarter?
Thomas Barbato: Yes. I mean I'll just say that our gross margins in Q4 are always the highest margins in the year, right? So as an example, last year, in Q4, we were at 36.2% margins. But I would say that we incurred start-up costs this quarter related to the revenue increase. I think there'll be new customers that onboard next quarter. But as we kind of said in our prepared remarks, right, I mean that will normalize. It's not -- we're not talking years out, right? We're talking normalizing over the next few quarters and seeing margin expansion.
Operator: [Operator Instructions] We go next now to Ted Jackson of Northland.
Edward Jackson: To reiterate, congratulations on the quarter. I got 2 or 3 questions for you. Let's -- I want to talk a little bit first about kind of the longer term. And if you think about going out a couple of years, a lot of shifts with regards to administration driven spending. So if you think about Life Sciences, which is your kind of your bread and butter, your core vertical, your favorite place to play. You look at a lot of efforts to drive pharmaceutical manufacturing in the United States. You've seen no Lilly is going to spend $30 billion to put manufacturing in Alabama, Pennsylvania, Texas, Virginia, AstraZeneca's pledged $50 billion, Amgen's talking about opening up new facilities in the Midwest and the Atlantic Seaboard. When I think -- when I hear all this kind of stuff, it seems to me that this is a really substantial amount of wind in your sales as you look out, say, 5 years and beyond. And so I mean how would an investor over the long term, think about this stuff? How do you guys think about it? And kind of handicap it. And then like maybe [ in turn ] perspective, and I know every manufacturing plant is different. But when you get into like a new plant, say, like in the Wall Street Journal last week, one of the Lilly plants was decided in terms of where it was going to be in Pennsylvania, something like that when it's built, what's the revenue opportunity for a company like Transcat when it happens? That's my first question. And actually, since there's a similar -- my second question really is the same, but just on defense. It's a little less specific. But I mean, if you look at the defense spending. I mean they're talking about $1.5 trillion of spending next year. And if you look at some of the major contractors like Lockheed and RTX and Northrop. I mean they're talking about like 30% increases in their CapEx. So maybe a discussion with regards to aerospace and defense. That's my first question.
Lee Rudow: Okay. Ted, this is Lee. So I'll take a shot at this and certainly Tom can fill in. But you're spot on. It's pretty simple for us. Any onshoring of manufacturing. In the regulated business space is always going to be good for Transcat. So AstraZeneca, of course, they're on our radar. You mentioned Lilly, they're on our radar. This is good for us. And to the degree it comes true, comes to fruition. And then over the next couple of years, we'll be ready and we'll be working to gain that business, right? No question. When you look at the life cycle of a project, a capital project, it kind of starts from the building of the actual physical plant all the way through to buying equipment, commissioning equipment, validating equipment, ultimately calibrating equipment for an upstart and then calibrating equipment as time goes by on a regular basis. There's half a dozen phases. Transcat is capable of participating in most of those. Obviously, calibration is our bread and butter. We do commissioning and validation as well. And it's always on our radar to look for those opportunities. So we'll call them capital projects. So yes, we can participate. I think over time, as we expand our addressable markets, we'll be able to participate even more. But it's right down our wheelhouse for most of that work. And it is on our radar and onshoring is good. As far as defense goes, same basic story there, right? A lot of the defense contractors, like Lockheed, have their own in-house calibration labs. And so in that case, we'll do the overflow work. We could do their standards. And occasionally, we actually do the work in any particular plant. But the more defense contracting work there is, the bigger the government gets from that perspective. That's a highly regulated space, which means it's a good space for Transcat.
Thomas Barbato: Yes. And I think you specifically referenced their CapEx budgets and the increases in CapEx budgets. The more equipment that's out there, that's good for Transcat, right? And the ultimate kind of brass ring for us is that recurring revenue, right? So we've got a broad offering the broadest in the industry, right, that allows us to participate in all of those aspects of a new plant being built, but the brass ring for us is clearly the recurring revenue streams, and that's the calibration work that takes place there.
Edward Jackson: But like the bread and butter business that you guys operate in, I mean, you talk about it every quarter, 60-plus quarters of growth. I mean, you have been able to grow your business organically for conversation's sake, we're just call it 7%. For years, which just as your business grows 7%. When you see this kind of stuff happening, does it make you recalibrate what you think you could grow organically if it comes to pass? I mean, is there a case to be made that we get towards the end of the decade, and the organic growth rate for Transcat might tick up because you're seeing all this investment and all this has -- like there's, I don't know, like update in the Higton as these things are coming online?
Lee Rudow: Well, I mean there's 2 ways I look at that. One is to say even over the past 10 years and maybe we've averaged 8% growth over the last 5, there are quarters and there have been quarters when we have double-digit growth. So it's not impossible for us to do that. And I would expect that you're going to see that at different points. We're comfortable in the high single-digit range because it just makes sense for us, and that's where we are more consistently in that range than above that. We have cores when we're not -- when we don't meet our goals. And remember also, I mean we're a bigger company today. When we started in 2011, I think we had $30 million of calibration that stays $230 million in that range. And so the number gets bigger and obviously, to grow on a larger base or larger number is a challenge too. But I think Tom and I and the entire management team when we look at our strategic planning, organic and inorganic, we're thinking to ourselves we don't see a reason why we can't get in the high single-digit range on a pretty darn consistent basis. So I think it includes all the variables that you're mentioning.
Edward Jackson: Okay. And then just my final question for you is just jumping over to the CEO search. You put a charge in it. You -- could you just kind of -- is it fair to expect to see the conclusion of your efforts during this quarter? Would we -- would we have some clarity by the time you report your fourth quarter?
Lee Rudow: I think that's a reasonable expectation.
Edward Jackson: Okay. And then would there be -- given the charge, which was a new line item within the pro forma earnings, will we see additional onetime expenses associated with that search in the fourth quarter?
Thomas Barbato: There will be some additional expenses in the fourth quarter, yes.
Operator: And gentlemen, it appears we have no further questions this afternoon. I'd like to turn the conference back to you, Mr. Howe for any concluding remarks..
John Howe: Thank you all for joining us for today's call. We look forward to sharing more on our story at upcoming investor events, including facility tours, institutional investor conferences and nondeal roadshows across key cities throughout the United States in the spring of 2026. If we were unable to answer any of your questions, please reach out to our IR firm, MZ Group, who would be more than happy to assist. Thanks again for your interest.
Operator: Thank you, gentlemen. Again, that will conclude today's Transcat Third Quarter Fiscal Year 2026 Financial Results call. Again, thank you so much for joining us, everyone. We wish you all a great day. Goodbye.